Cysteinemia, rather than homocysteinemia, is associated with plasma apolipoprotein A-I levels in hyperhomocysteinemia. Lipid metabolism in cystathionine β-synthase deficiency.

Atherosclerosis

Volumn 212, Issue 1, 2010, Pages 268-273

  Nuño Ayala, Mario ^a   Guillén, Natalia ^a,c   Navarro, María A ^a,c   Lou Bonafonte, Jose M ^a   Arnal, Carmen ^b,c   Gascón, Sonia ^a,c   Barranquero, Cristina ^a,c   Godino, Javier ^a   Royo Cañas, María ^a   Sarría, Alfonso J ^a,c   Guzmán, Mario A ^a   Hernandez, Esther ^b   Bregante, Miguel A ^b   García Gimeno, María A ^b   Osada, Jesús ^a,c  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b UNIVERSIDAD DE ZARAGOZA   (Spain)

^c Instituto de Salud Carlos III   (Spain)

Author keywords

Apolipoproteins; Cystathionine synthase deficient mice; Cysteine; Homocysteine; Methionine

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN A5; APOLIPOPROTEIN C3; CHOLESTEROL; CYSTEINE; GLUCOSE; GLUTATHIONE; GLYCINE; HOMOCYSTEINE; INSULIN; INTERLEUKIN 6; LEPTIN; MESSENGER RNA; METHIONINE; MONOCYTE CHEMOTACTIC PROTEIN 1; RESISTIN; RNA; TISSUE PLASMINOGEN ACTIVATOR; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENDOTHELIUM CELL; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HOMOCYSTINURIA; HOMOZYGOSITY; HYPERHOMOCYSTEINEMIA; INSULIN BLOOD LEVEL; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; LIVER; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; WILD TYPE;

EID: 77956227934     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.04.028     Document Type: Article

References (30)

1. McCully K.S. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969, 56:111-128.
2. Eikelboom J.W., Lonn E., Genest J., Hankey G., Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999, 131:363-375.
3. Wald D.S., Law M., Morris J.K. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002, 325:1202.
4. Dayal S., Lentz S.R. Murine models of hyperhomocysteinemia and their vascular phenotypes. Arterioscler Thromb Vasc Biol 2008, 28:1596-1605.
5. Watanabe M., Osada J., Aratani Y., et al. Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia. Proc Natl Acad Sci USA 1995, 92:1585-1589.
6. Chen Z., Karaplis A.C., Ackerman S.L., et al. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum Mol Genet 2001, 10:433-443.
7. Swanson D.A., Liu M.L., Baker P.J., et al. Targeted disruption of the methionine synthase gene in mice. Mol Cell Biol 2001, 21:1058-1065.
8. Namekata K., Enokido Y., Ishii I., et al. Abnormal lipid metabolism in cystathionine beta-synthase-deficient mice, an animal model for hyperhomocysteinemia. J Biol Chem 2004, 279:52961-52969.
9. Hamelet J., Demuth K., Paul J.L., Delabar J.M., Janel N. Hyperhomocysteinemia due to cystathionine beta synthase deficiency induces dysregulation of genes involved in hepatic lipid homeostasis in mice. J Hepatol 2007, 46:151-159.
10. Guillen N., Navarro M.A., Arnal C., et al. Microarray analysis of hepatic gene expression identifies new genes involved in steatotic liver. Physiol Genomics 2009, 37:187-198.
11. Liao D., Tan H., Hui R., et al. Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I protein synthesis and enhancing HDL cholesterol clearance. Circ Res 2006, 99:598-606.
12. Mikael L.G., Genest J., Rozen R. Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease. Circ Res 2006, 98:564-571.
13. Akahoshi N., Kobayashi C., Ishizaki Y., et al. Genetic background conversion ameliorates semi-lethality and permits behavioral analyses in cystathionine beta-synthase-deficient mice, an animal model for hyperhomocysteinemia. Hum Mol Genet 2008, 17:1994-2005.
14. Selhub J. Homocysteine metabolism. Annu Rev Nutr 1999, 19:217-246.
15. Velez-Carrasco W., Merkel M., Twiss C.O., Smith J.D. Dietary methionine effects on plasma homocysteine and HDL metabolism in mice. J Nutr Biochem 2008, 19:362-370.
16. Guzman M.A., Navarro M.A., Carnicer R., et al. Cystathionine beta-synthase is essential for female reproductive function. Hum Mol Genet 2006, 15:3168-3176.
17. Garrido N., Perez-Martos A., Faro M., et al. Cisplatin-mediated impairment of mitochondrial DNA metabolism inversely correlates with glutathione levels. Biochem J 2008, 414:93-102.
18. Pastore A., Massoud R., Motti C., et al. Fully automated assay for total homocysteine, cysteine, cysteinylglycine, glutathione, cysteamine, and 2-mercaptopropionylglycine in plasma and urine. Clin Chem 1998, 44:825-832.
19. Navarro M.A., Carpintero R., Acin S., et al. Immune-regulation of the apolipoprotein A-I/C-III/A-IV gene cluster in experimental inflammation. Cytokine 2005, 31:52-63.
20. Calleja L., Paris M.A., Paul A., et al. Low-cholesterol and high-fat diets reduce atherosclerotic lesion development in ApoE-knockout mice. Arterioscler Thromb Vasc Biol 1999, 19:2368-2375.
21. Guillen N., Acin S., Navarro M.A., et al. Squalene in a sex-dependent manner modulates atherosclerotic lesion which correlates with hepatic fat content in apoE-knockout male mice. Atherosclerosis 2008, 196:558-564.
22. Acin S., Navarro M.A., Arbones-Mainar J.M., et al. Hydroxytyrosol administration enhances atherosclerotic lesion development in apo E deficient mice. J Biochem (Tokyo) 2006, 140:383-391.
23. Singh R., Kaushik S., Wang Y., et al. Autophagy regulates lipid metabolism. Nature 2009, 458:1131-1135.
24. Werstuck G.H., Lentz S.R., Dayal S., et al. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest 2001, 107:1263-1273.
25. Ji C. Dissection of endoplasmic reticulum stress signaling in alcoholic and non-alcoholic liver injury. J Gastroenterol Hepatol 2008, 23(Suppl. 1):S16-S24.
26. Henkel A.S., Elias M.S., Green R.M. Homocysteine supplementation attenuates the unfolded protein response in a murine nutritional model of steatohepatitis. J Biol Chem 2009, 284:31807-31816.
27. Timmins J.M., Lee J.Y., Boudyguina E., et al. Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. J Clin Invest 2005, 115:1333-1342.
28. von Eckardstein A., Rohrer L. Transendothelial lipoprotein transport and regulation of endothelial permeability and integrity by lipoproteins. Curr Opin Lipidol 2009, 20:197-205.
29. Hamelet J., Ait-Yahya-Graison E., Matulewicz E., et al. Homocysteine threshold value based on cystathionine beta synthase and paraoxonase 1 activities in mice. Eur J Clin Invest 2007, 37:933-938.
30. Ritter M., Buechler C., Boettcher A., et al. Cloning and characterization of a novel apolipoprotein A-I binding protein, AI-BP, secreted by cells of the kidney proximal tubules in response to HDL or ApoA-I. Genomics 2002, 79:693-702.